|
rs1799883
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The alanine to threonine amino acid substitution at codon 54 (Ala54Thr) of the intestinal fatty acid binding protein (FABP2) has been associated with elevated levels of insulin and blood glucose as well as with dyslipidemia.
|
26703680 |
2015 |
|
rs1799883
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The results from the published studies on the association of fatty acid-binding protein 2 (FABP2) Ala54Thr polymorphism with dyslipidemia are conflicting and inconclusive.
|
20047744 |
2010 |
|
rs1799883
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Our objectives were to determine whether Ala54Thr FABP2 and G-493T MTP polymorphisms are associated with increased risks of insulin resistance syndrome (IRS) in youth and/or modify the expression of accompanying dyslipidemia.
|
15547295 |
2005 |
|
rs1799883
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Our data suggested that Ala54Thr polymorphism of the FABP2 gene is not a major contributing factor for obesity and obesity with dyslipidemia in Japanese children.
|
11866034 |
2001 |
|
rs1799883
|
|
|
0.050 |
GeneticVariation |
BEFREE |
To investigate whether or not the intestinal fatty acid binding protein gene (FABP2)-Ala54Thr variation is related to non-insulin dependent diabetes mellitus (NIDDM), obesity, dyslipidemia and glucose stimulated insulin secretion (GSIS) in Chinese.
|
11593593 |
1999 |
|
rs1217691063
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Further studies are needed to confirm the role of tHcy and the MTHFR C677T mutation in the development of dyslipidemia in a larger sample.
|
26442927 |
2017 |
|
rs1217691063
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In conclusion, in these type 2 diabetic outpatients circulating levels of tHcy, folate, and the MTHFR C677T mutation are not associated with DPN, which was predicted by creatinine levels, CHD, and dyslipidemia.
|
26233336 |
2016 |
|
rs1217691063
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Supplementation with Watermelon Extract Reduces Total Cholesterol and LDL Cholesterol in Adults with Dyslipidemia under the Influence of the MTHFR C677T Polymorphism.
|
26934084 |
2016 |
|
rs1217691063
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The aim of the present study was to evaluate the effect of simvastatin treatment on circulating Hcy levels in obese women without hypertension, diabetes or dyslipidaemia; and to determine whether the 677C>T polymorphism located in methylenetetrahydrofolate reductase (NAD(P)H) (MTHFR) gene modulates the effects of this treatment on Hcy and nitrite (as a biomarker of nitric oxide (NO) bioavailability).
|
25115547 |
2014 |
|
rs671
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The <i>ALDH2</i> rs671 genotypes indicated that the gene-related drinking habit and gene variant altogether may affect hypertension and dyslipidemia.
|
31361523 |
2019 |
|
rs670
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Results revealed significant differences in rs670 and rs2292318 allele frequencies between cases and controls (P<0.025). rs670 G allele carriers were more likely to develop dyslipidemia than A allele carriers (OR = 1.315, OR 95% CI: 1.067-2.620; P = 0.010). rs2292318 T allele carriers were more likely to develop dyslipidemia than A allele carriers (OR = 1.264, OR 95% CI: 1.037-1.541; P = 0.020).
|
29758034 |
2018 |
|
rs671
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Interactions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: A guide to targeted heart health management.
|
29960587 |
2018 |
|
rs780094
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The results of this population-based study provide evidence for a relationship between lipid regulatory gene polymorphisms including GCKR (rs780094), GCKR (rs1260333), FADS (rs174547), and MLXIPL (rs3812316) with dyslipidemia in an Iranian population.
|
29858861 |
2018 |
|
rs662799
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our data indicate that the rs662799 polymorphism is associated with dyslipidemia and the severity of CHD in Chinese women.
|
27716220 |
2016 |
|
rs670
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The frequencies of the A allele for rs670 were found to be 14.3% (dyslipidemia group) and 12.7% (control group).
|
27173266 |
2016 |
|
rs662799
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The objective of this study was to analyze the interaction of a high fat diet with the APOA2 (rs3813627 and rs5082), APOA5 (rs662799 and rs3135506) and LEPR (rs8179183 and rs1137101) polymorphisms and its relationship with obesity and dyslipidemia in young subjects.
|
26365669 |
2015 |
|
rs773641005
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The alanine to threonine amino acid substitution at codon 54 (Ala54Thr) of the intestinal fatty acid binding protein (FABP2) has been associated with elevated levels of insulin and blood glucose as well as with dyslipidemia.
|
26703680 |
2015 |
|
rs1800206
|
|
|
0.030 |
GeneticVariation |
BEFREE |
When the most common haplotype L-G (established by r</span>s1800206, rs4253778) was treated as the reference group, the V-G haplotype was associated with dyslipidemia (P < 0.001), higher TC and TG levels (P < 0.01).
|
24460649 |
2014 |
|
rs671
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Furthermore, the ALDH2 Glu504Lys polymorphism has been shown to be associated with certain traditional cardiovascular risk factors, such as dyslipidemia, hypertension, and diabetes mellitus or hyperglycemia.
|
25263942 |
2014 |
|
rs1260326
|
|
|
0.030 |
GeneticVariation |
BEFREE |
There were significant associations between rs1260333 (OR is 0.82, 95 % CI 0.74-0.92, p ~ 3.96 × 10(-4)), rs1260326 (OR is 0.82, 95 % CI 0.74-0.92, p ~ 5.31 × 10(-4)), and rs964184 (OR is 1.36, 95 % CI 1.20-1.55, p ~ 1.89 × 10(-6)) and dyslipidemia.
|
23832694 |
2013 |
|
rs662799
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Multivariable logistic regression analysis of combined genotypes with adjustment for age, gender and diabetes mellitus revealed that rs662799 and rs6929846 significantly and synergistically affected dyslipidemia.
|
22576629 |
2012 |
|
rs670
|
|
|
0.030 |
GeneticVariation |
BEFREE |
ApoB rs512535 and ApoA1 rs670 major G allele homozygotes had increased MetS risk (OR 1.65 [CI 1.24, 2.20], P = 0.0006; OR 1.42 [CI 1.08, 1.87], P = 0.013), which may be, partly, explained by their increased abdominal obesity and impaired insulin sensitivity (P<0.05) but not dyslipidemia.
|
21122859 |
2011 |
|
rs780094
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Consistent with observations in white Europeans, the GCKR rs780094 polymorphism contributes to the risk of type 2 diabetes and dyslipidaemia in Han Chinese individuals.
|
19241058 |
2009 |
|
rs1260326
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We evaluated, in a general French population, the contribution of the GCKR rs1260326-P446L polymorphism to quantitative metabolic parameters and to dyslipidemia and hyperglycemia risk.
|
18556336 |
2008 |
|
rs1260326
|
|
|
0.030 |
GeneticVariation |
BEFREE |
A polymorphism in the GCKR gene predicted dyslipidaemia (rs1260326, OR 1.15, 95% CI 1.09-1.22, p < 0.00001) but not the metabolic syndrome.
|
18853134 |
2008 |